Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,840,000 | 6,166,000 | 6,329,000 | 7,832,000 | 5,369,000 |
| Marketable Securities | 238,000 | 326,000 | 152,000 | 302,000 | 885,000 |
| Receivables | 13,552,000 | 11,252,000 | 10,307,000 | 7,386,000 | 6,046,000 |
| Inventories | 5,424,000 | 4,699,000 | 8,983,000 | 4,024,000 | 3,193,000 |
| Other current assets | 0 | 150,000 | 473,000 | 0 | 70,000 |
| TOTAL | $25,054,000 | $22,593,000 | $26,244,000 | $19,544,000 | $15,563,000 |
| Non-Current Assets | |||||
| PPE Net | 9,402,000 | 8,507,000 | 9,183,000 | 8,251,000 | 7,688,000 |
| Investments And Advances | 1,905,000 | 1,216,000 | 1,339,000 | 1,318,000 | 1,520,000 |
| Intangibles | 58,137,000 | 59,127,000 | 62,384,000 | 32,792,000 | 32,501,000 |
| Other Non-Current Assets | 6,621,000 | 5,040,000 | 6,213,000 | 4,824,000 | 4,105,000 |
| TOTAL | $76,065,000 | $73,890,000 | $79,119,000 | $47,185,000 | $45,814,000 |
| Total Assets | $101,119,000 | $96,483,000 | $105,363,000 | $66,729,000 | $61,377,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,129,000 | 5,314,000 | 1,660,000 | 2,194,000 | 1,822,000 |
| Accounts payable and accrued liabilities | 22,374,000 | 19,040,000 | 18,938,000 | 15,785,000 | 13,987,000 |
| Other current liabilities | 1,184,000 | 815,000 | 847,000 | 1,009,000 | 759,000 |
| TOTAL | $30,542,000 | $26,293,000 | $22,594,000 | $20,307,000 | $18,117,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,365,000 | 22,965,000 | 28,134,000 | 17,505,000 | 15,730,000 |
| Other Non-Current Liabilities | 6,196,000 | 7,218,000 | 9,139,000 | 10,413,000 | 10,552,000 |
| TOTAL | $31,411,000 | $33,132,000 | $43,482,000 | $30,784,000 | $28,664,000 |
| Total Liabilities | $61,953,000 | $59,425,000 | $66,076,000 | $51,091,000 | $46,781,000 |
| Shareholders' Equity | |||||
| Common Shares | 388,000 | 387,000 | 387,000 | 328,000 | 328,000 |
| Retained earnings | 1,502,000 | -574,000 | 1,710,000 | 5,299,000 | 2,812,000 |
| Other shareholders' equity | 2,088,000 | 2,090,000 | 2,064,000 | 2,040,000 | 3,515,000 |
| TOTAL | $39,166,000 | $37,058,000 | $39,287,000 | $15,638,000 | $14,596,000 |
| Total Liabilities And Equity | $101,119,000 | $96,483,000 | $105,363,000 | $66,729,000 | $61,377,000 |